Evaluation of Early CRRT InTerventions in Patients With ECMO(ELITE)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 131 participants.
Also called NCT03549923
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 131 participants
- Registry
-
NCT03549923
-
- Other papers using this trial's data
- Effects of early continuous renal replacement therapy in critically ill patients requiring ECMO treatment: results of a randomised controlled trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT03549923. Randomized; no masking; primary purpose treatment. Start 2018-12-18 (actual); primary completion 2022-10-22 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of Early CRRT InTerventions in Patients With ECMO(ELITE)
- Acronym
- ELITE
- Condition
- Cardiogenic Shock
- Intervention (Device)
- Simultaneous CRRT
- Intervention (Device)
- Conventional-indication CRRT
- Intervention (Drug)
- Esmolol
- Intervention (Drug)
- Standard care
- Lead sponsor
- Beijing Anzhen Hospital
- Collaborator
- The First Affiliated Hospital of Zhengzhou University
Record details
- Record id
cardio:ct-nct03549923- Content hash
7ba34760dd68348f1556e2f4840ae688845cef295867832dad695073e3164b88